Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
10%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FMED
74
HOLDINGS
20%
ALSO IN SBIO
SBIO
87
HOLDINGS
16%
ALSO IN FMED
SECTOR DRIFT (FMED minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FMED |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 1.6% | 4.5% | 1.6% |
|
DISC MEDICINE, INC. | 1.2% | 1.5% | 1.2% |
|
VIRIDIAN THERAPEUTICS INC | 1.2% | 1.1% | 1.1% |
|
STOKE THERAPEUTICS, INC. | 1.1% | 1.0% | 1.0% |
|
AMYLYX PHARMACEUTICALS, INC. | 0.9% | 1.0% | 0.9% |
FMED Overweight Relative to SBIO
|
LIFESTANCE HEALTH GROUP, INC. | 4.8% |
|
10X GENOMICS INC CLASS A | 3.6% |
 |
UCB SA | 3.2% |
|
DANAHER CORP | 3.2% |
|
MODERNA, INC. | 2.8% |
|
COGENT BIOSCIENCES INC | 2.7% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
ARGENX SE ADR | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
BIO-TECHNE CORPORATION | 2.4% |
FMED Underweight Relative to SBIO
|
APOGEE THERAPEUTICS, INC. | -4.2% |
|
CG ONCOLOGY, INC. | -3.4% |
|
CRINETICS PHARMACEUTICALS INC | -2.9% |
|
DIANTHUS THERAPEUTICS INC | -2.7% |
|
TRAVERE THERAPEUTICS, INC. | -2.7% |
|
DEFINIUM THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.5% |
|
ORUKA THERAPEUTICS INC | -2.5% |
|
ACADIA PHARMACEUTICALS INC | -2.3% |
|
DENALI THERAPEUTICS INC. | -2.1% |